The so-called VAMPIRE project ('Vascular Antibody-Mediated Pharmaceutically Induced tumour Resection') is led by the University of Birmingham in the UK and SomantiX, a Dutch biotech company based in Utrecht.
Projekti VAMPIRE („Vascular Antibody-Mediated Pharmaceutically Induced tumour Resection”) juhivad Birminghami Ülikool (Ühendkuningriik) ja SomantiX, Utrechtis asuv Madalmaade biotehnoloogiaettevõte.